Product Information
RUFINAMIDE 200 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.8320 per EA under NDC 00054042523. Its NADAC has been published 201 times since Sep 21, 2022.
FDA first approved this application on May 16, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054042523
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RUFINAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204988FDA Approved
5/16/2016
TE Code
AB
On Market Since
5/30/2021
Price Statistics
The NADAC for RUFINAMIDE 200 MG TABLET has been published 201 times since Sep 21, 2022, and over the history we have for it it has declined 65.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8320 per EA |
|---|---|
| All-time high | $2.3971 (Sep 13, 2023) |
| All-time low | $0.8320 (Aug 19, 2026) |
| 52-week high | $1.5100 |
| 52-week low | $0.8320 |
| Median price | $1.5778 |
| Average price | $1.7039 |
| Largest weekly change | -14.2% (Nov 19, 2025) |
| Weeks tracked | 201 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RUFINAMIDE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RUFINAMIDE 200 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.8320 per EA (NDC 00054042523), effective Aug 19, 2026.
How has the price of RUFINAMIDE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for RUFINAMIDE 200 MG TABLET has declined 65.3%. It has been tracked across 201 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for RUFINAMIDE 200 MG TABLET?
Since Sep 21, 2022, the NADAC for RUFINAMIDE 200 MG TABLET has ranged from a low of $0.8320 (Aug 19, 2026) to a high of $2.3971 (Sep 13, 2023), with a median of $1.5778 per EA.
Are there cheaper alternatives to RUFINAMIDE 200 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RUFINAMIDE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RUFINAMIDE 200 MG TABLET?
RUFINAMIDE 200 MG TABLET (NDC 00054042523) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.